REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro de Tratamiento Hematologico Hemacent S.A. (Ecuador)

Main Activities: Medical and Diagnostic Laboratories
Secondary Activities: Blood and Organ Banks
Full name: Centro de Tratamiento Hematologico Hemacent S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Centro de Tratamiento Hematologico Hemacent S.A. is based in Ecuador. The head office is in Guayaquil. The company operates in the Medical and Diagnostic Laboratories industry. The company was established on July 18, 2018. The total number of employees is currently 4 (2022). Its’ total assets recorded a growth of 63.47%.

Headquarters
Babahoyo 0435
Guayaquil; Guayas;

Contact Details: Purchase the Centro de Tratamiento Hematologico Hemacent S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Centro de Tratamiento Hematologico Hemacent S.A. report to view the information.
Outstanding Shares:
Purchase the Centro de Tratamiento Hematologico Hemacent S.A. report to view the information.
Registered Capital:
Purchase the Centro de Tratamiento Hematologico Hemacent S.A. report to view the information.
Incorporation Date:
July 18, 2018
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Centro de Tratamiento Hematologico Hemacent S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net Profit (Loss) for the Period
194.96%
Total assets
63.47%
Total equity
44.48%
Return on Equity (ROE)
23.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?